Effect of anaphylatoxin C3a, C5a on the tubular epithelial-myofibroblast transdifferentiation in vitro

Chinese Medical Journal

Volumn 124, Issue 23, 2011, Pages 4039-4045

  Liu, Fang ^a   Gou, Rong ^a   Huang, Jun ^a   Fu, Ping ^a   Chen, Feng ^a   Fan, Wen Xing ^a   Huang, You Qun ^a   Zang, Li ^a   Wu, Min ^a   Qui, Hong Yu ^a   Wei, Da Peng ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

C3a; C5a; Connective tissue growth factor; Transforming growth factor 1; Tubular epithelial myofibroblast transdifferentiation

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3A RECEPTOR; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT RECEPTOR; CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; RECEPTOR BLOCKING AGENT; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; CELL STRUCTURE; CELL SURFACE; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INTRACELLULAR SIGNALING; KIDNEY CELL CULTURE; KIDNEY TUBULE CELL; MICROVILLUS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; TUBULAR EPITHELIAL MYOFIBROBLAST TRANSDIFFERENTIATION; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CADHERINS; CELL LINE; CELL TRANSDIFFERENTIATION; COMPLEMENT C3A; COMPLEMENT C5A; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, SCANNING; MYOFIBROBLASTS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84862958865     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.23.036     Document Type: Article

References (34)

1. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995; 130: 393-405.
2. Berger SP, Roos A, Daha MR. Complement and the kidney: what the nephrologist needs to know in 2006? Nephrol Dial Transplant 2005; 20: 2613-2619.
3. Li K, Patel H, Farrar CA, Hargreaves RE, Sacks SH, Zhou W. Complement activation regulates the capacity of proximal tubular epithelial cell to stimulate alloreactive T cell response. J Am Soc Nephrol 2004; 15: 2414-2422.
4. Boor P, Konieczny A, Villa L, Schult AL, Bücher E, Rong S, et al. Complement C5 mediates experimental tubulointerstitial fibrosis. J Am Soc Nephrol 2007; 18: 1508-1515.
5. Sacks SH, Zhou W, Sheerin NS. Complement synthesis in the injured kidney: Does it have a role in immune complex glomerulonephritis? J Am Soc Nephrol 1996; 7: 2314-2319.
6. Braun MC, Reins RY, Li TB. Renal expression of the C3a receptor and functional responses of primary human proximal tubular epithelial cells. J Immunol 2004; 2: 4190-4196.
7. Zahedi R, Braun M, Wetsel RA. The C5a receptor is expressed by human renal proximal tubular epithelial cells. Clin Exp Immunol 2000; 121: 226-232.
8. Schulze M, Donadio JV Jr, Pruchno CJ. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy. Kidney Int 1991; 40: 533-538.
9. Morita Y, Ikeguchi H, Nakamura J, Hotta N, Yuzawa Y, Matsuo S. Complement activation products in the urine from proteinuric patients. J Am Soc Nephrol 2000; 11: 700-707.
10. Ogrodowski JL, Hebert LA, Sedmak D, Cosio FG, Tamerius J, Kolb W. Measurement of C5b-9 in urine in patients with the nephrotic syndrome. Kidney Int 1991; 40: 1141-1147.
11. Abe K, Li K, Sacks SH, Sheerin NS. The membrane attack complex, C5b-9, up regulates collagen gene expression in renal tubular epithelial cells. Clin Exp Immunol 2004; 136: 60-66.
12. Turnberg D, Lewis M, Moss J, Xu Y, Botto M, Cook HT. Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice. J Immunol 2006; 177: 4094-4102.
13. Welch TR, Frenzke M, Witte D, Davis AE. C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis. Clin Exp Immunol 2002; 130: 43-48.
14. Rangan GK, Pippin JW, Couser WG. C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis. Kidney Int 2004; 66: 1838-1848.
15. Nomura A, Morita Y, Maruyama S, Hotta N, Nadai M, Wang L, et al. Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis. Am J Pathol 1997; 151: 539-547.
16. He C, Imai M, Song H, Quigg RJ, Tomlinson S. Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9. J Immunol 2005; 174: 5750-5757.
17. Sheerin NS, Sacks SH. Leaked protein and interstitial damage in the kidney: is complement the missing link? Clin Exp Immunol 2002; 130: 1-3.
18. Morita Y, Ikeguchi H, Nakamura J, Hotta N, Yuzawa Y, Matsuo S. Complement activation products in the urine from proteinuric patients. J Am Soc Nephrol 2000; 11: 700-707.
19. Nath KA, Hostetter MK, Hostetter TH. Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 1985; 76: 667-675.
20. Nangaku M, Pippin J, Couser WG. C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys. J Am Soc Nephrol 2002; 13: 928-936.
21. Rangan GK, Pippin JW, Couser WG. C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis. Kidney Int 2004; 66: 1838-1848.
22. Tang Z, Lu B, Hatch E, Sacks SH, Sheerin NS. C3a mediates epithelial-to-mesenchymal transition in proteinuric nephropathy. J Am Soc Nephrol 2009; 20: 593-603.
23. Eitner F, Floege J. Therapeutic targets for prevention and regression of progressive fibrosing renal diseases. Curr Opin Investig Drugs 2005; 6: 255-261.
24. Ostendorf T, Rong S, Boor P, Wiedemann S, Kunter U, Haubold U, et al. Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol 2006; 17: 1054-1062.
25. Boor P, Konieczny A, Villa L, Kunter U, van Roeyen CR, LaRochelle WJ, et al. PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis. Nephrol Dial Transplant 2007; 22: 1323-1331.
26. Ostendorf T, Rong S, Boor P, Wiedemann S, Kunter U, Haubold U, et al. Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol 2006; 17:1054-1062.
27. Ostendorf T, Kunter U, Gröne HJ, Bahlmann F, Kawachi H, Shimizu F, et al. Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol 2001; 12: 909-918.
28. Tang WW, Ulich TR, Lacey DL, Hill DC, Qi M, Kaufman SA, et al. Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. Am J Pathol 1996; 148: 1169-1180.
29. Ito Y, Aten J, Nguyen TQ, Joles JA, Matsuo S, Weening JJ, et al. Involvement of connective tissue growth factor in human and experimental hypertensive nephrosclerosis. Nephron Exp Nephrol 2010; 4: e9-e20.
30. Burns WC, Thomas MC. The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology. Expert Rev Mol Med 2010; 27: 12-17.
31. Gerritsen KG, Peters HP, Nguyen TQ, Koeners MP, Wetzels JF, Joles JA, et al. Renal proximal tubular dysfunction is a major determinant of urinary connective tissue growth factor excretion. Am J Physiol Renal Physiol 2010; 298: 1457-1464.
32. Li Y, Zhang J, Fang L, Luo P, Peng J, Du X. Lefty A attenuates the TGF-beta1-induced epithelial to mesenchymal transition of human renal proximal epithelial tubular cells. Mol Cell Biochem 2010; 339: 263-270.
33. Phanish MK, Winn SK, Dockrell ME. Connective tissue growth factor-(CTGF, CCN2): a marker, mediator and therapeutic target for renal fibrosis. Nephron Exp Nephrol 2010; 114: 83-92.
34. Burns WC, Twigg SM, Forbes JM, Pete J, Tikellis C, Thallas-Bonke V, et al. Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease. J Am Soc Nephrol 2006; 17: 2484-2494.